Tecan推出Freedom EVO全自动液体工作站用于药物发现
RESEARCH TRIANGLE PARK, N.C. & BOSTON--(BUSINESS WIRE)--Aug. 12, 2003--Tecan US, a leader in the Life Sciences supply industry today launched Freedom EVO, a series of powerful laboratory automated workstations, at Drug Discovery Technology 2003. Freedom EVO is the next step in Tecan"s world-class Life Sciences laboratory automation and consolidates 20 years of liquid handling and robotic experience. The new, flexible and scalable platform delivers a wide range of automated applications in genomics, proteomics, drug discovery and clinical diagnostics. Freedom EVO has been developed according to worldwide regulatory standards including the EU IVD-D directive and provides comprehensive support for customers implementing the FDA"s 21 CFR Part 11 regulation.
According to Carl Severinghaus, President, Tecan US, "The Freedom EVO is an important next step in Tecan"s commitment to providing leading-edge Life Science solutions to the growing needs of the laboratory research community. This one modular platform provides our customers with the flexibility and adaptability to match all of their applications needs in each of Tecan"s four distinct business areas: genomics, proteomics, drug discovery and diagnostics."
Today"s laboratory researcher is faced with continually changing applications needs and requires automation products that are both easily installed and quickly re-configured. The Freedom EVO addresses these needs directly with its modular design that allows each system to be configured according to the customer"s unique requirements. The Freedom EVO also features straightforward integration of previously developed options and applications and ensures continuing compatibility with new solutions from a leading worldwide supplier of laboratory automation.
The Freedom EVO is available in a wide variety of sizes to meet different throughput requirements and is easily configured with options from Tecan"s extensive portfolio that covers detection, separation and storage. In addition, 3rd party devices and customized devices are easily integrated, delivering unmatched flexibility.
Tecan"s Freedom EVOware provides software control management in a new and easy to use software package that combines pipetting with scheduled operation of multiple devices in a single package. The new graphical user interface, combined with enhanced support for applications, streamlines the setup and assay running process, a significant time savings to researchers. Multilevel user management and full audit trail ensures that laboratories working in a regulated environment comply with the FDA"s CFR 21 Part 11.
Tecan"s development processes meet worldwide regulatory standards including the In-Vitro Diagnostics Directive 98/79/EC. Specific Freedom EVO configurations will be released for diagnostic applications making Freedom EVO the platform of choice for Clinical Diagnostics.
About Tecan
Tecan (www.tecan.com) is a leading player in the Life Sciences supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2002, Tecan achieved sales of CH 332.2 million (USD 212.9 million; EUR 226.0 million). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor : 1210019).
Contacts
Tecan US
Michele Valenta, 919-361-5200
or
Wilder Communications, Inc.
Lisa Wilder, 919-349-3357
厂家名称
关于帝肯 瑞士Tecan(www.tecan.com)是一家全球领先的生物制药、法医和临床诊断实验室仪器和解决方案供应商,专业从事生命科学领域实验室自动化流程解决方案的研发、生产和销售。我们的客户包括:生物制药、高校科研单位、法医公...